FCM
KITE

Frontier Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Frontier Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-159,631
Closed -$16.5M – 335
2017
Q2 		$16.5M Buy
159,631
+35,195
+28% +$2.87M 0.12% 206
2017
Q1 		$9.77M Sell
124,436
-342,056
-73% -$21.2M 0.07% 243
2016
Q4 		$20.9M Buy
466,492
+228,774
+96% +$11.2M 0.16% 187
2016
Q3 		$13.3M Buy
237,718
+19,117
+9% +$1.07M 0.11% 223
2016
Q2 		$10.9M Sell
218,601
-229,340
-51% -$11.3M 0.09% 228
2016
Q1 		$20.6M Buy
447,941
+191,177
+74% +$9.26M 0.16% 184
2015
Q4 		$15.8M Sell
256,764
-481,302
-65% -$33.9M 0.13% 209
2015
Q3 		$41.1M Sell
738,066
-257,538
-26% -$16.2M 0.35% 101
2015
Q2 		$60.7M Buy
995,604
+272,830
+38% +$15.6M 0.44% 73
2015
Q1 		$41.7M Buy
722,774
+460,525
+176% +$30.9M 0.3% 126
2014
Q4 		$15.1M Buy
262,249
+145,474
+125% +$6.12M 0.11% 232
2014
Q3 		$3.33M Buy
116,775
+32,815
+39% +$812K 0.03% 300
2014
Q2 		$2.43M Buy
+83,960
New +$2.5M 0.02% 304

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Frontier Capital Management's KITE Position: Q3 2017 in Review

Frontier Capital Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 159,631 shares — an estimated $16.5M sold.

Frontier Capital Management first reported a position in KITE in Q2 2014 and held it in 13 quarters. The position peaked at $60.7M in Q2 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Frontier Capital Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Frontier Capital Management sold 159,631 Kite Pharma, Inc. shares in Q3 2017, an estimated $16.5M.
  • Frontier Capital Management first reported a position in Kite Pharma, Inc. in Q2 2014 and held it in 13 quarters.
  • Frontier Capital Management's Kite Pharma, Inc. position peaked at $60.7M in Q2 2015.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Frontier Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.